Issue Price
₹135
Per Share
GMP
NIL
Grey Market
Est. Listing
₹135
Expected Price
Min. Application
₹270,000
2 lots × 1000 shares
Incorporated in 2017, Astonea Labs Ltd. is engaged in contract manufacturing of pharmaceutical and cosmetic products for companies both within India and internationally.The company manufactures and markets a variety of pharmaceutical and cosmetic products, including antibiotics, anti-cold medicines, antihistamines, and treatments for diabetes, heart, gynecological issues, infections, and more.The company offers skin, tooth, and hair care products in forms like gels, creams, and serums, and also trades packaging and raw materials for pharmaceutical and cosmetic industries, meeting industry standards.The company engages in contract manufacturing of pharmaceutical and cosmetic products, markets its own brands "Glow Up" and "Regero," plans to launch "Avicel," and exports to countries like Iraq and Yemen.Produts and Offerings:Products under our own brands: The company markets “Glow Up” skincare and “Regero” pharma products, offering diverse affordable solutions.Products under contract manufacturing: The company provides pharmaceutical and cosmetic products under contract manufacturing, primarily for domestic and export markets.As of August 16, 2024, the company had 217 employees on payroll.Competitive Strengths:Experienced management and dedicated employee baseScalable business modelWide and diverse range of product offeringsQuality Service
Astonea Labs Ltd proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| Market Maker | 144,000 | — | ₹1.94 Cr | — |
| TOTAL | 2,790,000 | 100.00% | ₹37.67 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,000 | ₹135,000 |
| Retail (Max) | 13 | 13,000 | ₹1,755,000 |
| sNII (Min) | 14 | 14,000 | ₹1,890,000 |
| bNII (Min) | 68 | 68,000 | ₹9,180,000 |
| Particulars | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue from Operations | 69.69 | 80.29 | 67.26 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 4.10 | 3.81 | 0.67 |
| Net Worth | 17.28 | 11.97 | 8.16 |
| Total Assets | 96.52 | 80.89 | 64.28 |
| Reserves & Surplus | 9.56 | 4.37 | 4.16 |
| Total Borrowings | 49.48 | 42.40 | 35.99 |